Wuxi AppTec Co Ltd (fra:WX8) Share Price

Company Profile

Business description
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
Contact
288 Fute Zhong Road
Waigaoqiao Free Trade Zone
Pudong New Area
Shanghai200131
CHN
T: +86 2150461111
https://www.wuxiapptec.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
33,834

Recommended

We’re encouraged that AMD will count Anthropic as a third leading AI customer, in addition to OpenAI and Meta.

Brian Colello, CPA | 23 July 2026

A closer look at the stocks and ETFs that captured Aussie investors’ attention in FY26.

Tyger Fitzpatrick | 23 July 2026

Where value remains in Australian banks.

Tyger Fitzpatrick | 23 July 2026

Index	Last price	Change	% Change
All Ordinaries	9,018.10	41.40	-0.46%
CAC 40	8,373.60	64.29	-0.76%
DAX 40	25,055.65	99.76	-0.40%
Dow JONES (US)	52,218.58	6.06	-0.01%
FTSE 100	10,718.52	1.55	0.01%
HKSE	25,210.81	318.15	1.28%
NASDAQ	25,690.90	146.30	-0.57%
Nikkei 225	66,422.60	307.00	0.46%
NZX 50 Index	13,795.31	32.13	0.23%
S&P 500	7,498.96	10.24	-0.14%
S&P/ASX 200	8,839.00	38.60	-0.43%
SSE Composite Index	3,876.78	9.74	0.25%